Journal of Neuroimmunology
Volume 239, Issue 1 , Pages 21-27, 28 October 2011

Immune-mediated myelitis associated with Hepatitis virus infections

  • Joerg-Patrick Stübgen

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Neurology and Neuroscience, Weill Cornell Medical College/New York Presbyterian Hospital, 525 East 68th Street, New York, NY 10065-4885, USA. Tel.: +1 212 746 2334; fax: +1 212 746 8742.

Received 31 May 2011; received in revised form 24 July 2011; accepted 2 September 2011. published online 26 September 2011.

Abstract 

Virus-induced spinal cord damage results from a cytolytic effect on anterior horn cells or from predominantly cellular immune-mediated damage of long white matter tracts. Infection with the hepatitis virus group, most notably hepatitis C virus, has infrequently been associated with the occurrence of myelitis. The pathogenesis of hepatitis virus-associated myelitis has not been clarified: virus-induced autoimmunity (humoral or cell-mediated, possibly vasculitic) seems the most likely disease mechanism. Limited available information offers no evidence of direct hepatitis virus infection of the spinal cord. Virus neuropenetration may occur after virus-infected mononuclear cells penetrate the blood–brain barrier, but a true neurolytic effect has not been demonstrated. Attacks of acute myelitis usually respond favorably to immunomodulatory therapy. Antiviral therapy plays no confirmed role in the treatment of acute bouts of myelitis, but may limit the relapsing course of HCV-associated myelitis.

Highlights

► The maps generated indicate the existing problems in the physical environment. ► The maps generated functioning as a guide for urbanization. ► The occupations would be most appropriate if they occurred in the favorable areas. ► The multicriterial analysis implies infinite scenarios. ► The favorability maps represent a surface of suitability.

Keywords: Myelopathy, Myelitis, Hepatitis, Virus, Post-infectious

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-5728(11)00254-2

doi:10.1016/j.jneuroim.2011.09.001

Journal of Neuroimmunology
Volume 239, Issue 1 , Pages 21-27, 28 October 2011